K. Thiel

Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice.

P. Wutzler, P. Langen, H. Rosenthal, 1982, Antiviral research.

Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.

P. Wutzler, J. Reefschlaeger, K. Thiel, 1986, Antiviral research.

[Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author's transl)].

P. Wutzler, R. Klöcking, B. Helbig, 1981, Die Pharmazie.

Antiviral activity of enzymatically oxidized caffeic acid against herpesvirus hominis type 1 and type 2.

P. Wutzler, R. Klöcking, B. Helbig, 1983, Acta virologica.

Morphological and biochemical criteria for evaluating cytotoxic effects of antiviral substances.

R. Klöcking, U. Eichhorn, K. Thiel, 1980, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[Antiviral activity of phenolic polymers against type 1 herpesvirus hominis].

P. Wutzler, R. Klöcking, B. Helbig, 1978, Die Pharmazie.

[In vitro studies of the antiviral activity of ammonium humate against herpes simplex virus type 1 and type 2 (author's transl)].

R. Klöcking, K. Thiel, M. Sprössig, 1977, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie.